Editorial: “being normal weight each day keeps NAFLD and fibrosis away”—the importance of reducing cumulative exposure to overweight
Alimentary Pharmacology & Therapeutics · 2023
DOI: 10.1111/apt.17460 ↗Kurz gefasst
Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2023. Verfasst von Yusuf Yilmaz. Beteiligte Einrichtung: Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
LINKED CONTENT This article is linked to Ajmera et al papers. To view these articles, visit https://doi.org/10.1111/apt.17452 and https://doi.org/10.1111/apt.17478
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.
- Institute of Gastroenterology, Marmara University, İstanbul, Turkey.
ORCID-Profile: Yusuf Yilmaz
Zitieren
APA
Yilmaz, Y. (2023). Editorial: “being normal weight each day keeps NAFLD and fibrosis away”—the importance of reducing cumulative exposure to overweight. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17460
Vancouver
Yilmaz Y. Editorial: “being normal weight each day keeps NAFLD and fibrosis away”—the importance of reducing cumulative exposure to overweight. Alimentary Pharmacology & Therapeutics. 2023. doi:10.1111/apt.17460
BibTeX
@article{Yilmaz2023,
author = {Yilmaz, Yusuf},
title = {Editorial: “being normal weight each day keeps NAFLD and fibrosis away”—the importance of reducing cumulative exposure to overweight},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
doi = {10.1111/apt.17460}
}
EUVIMED